OBJECTIVES: To describe changes in physical activity levels related to health-enhancing physical activity guidelines during and after adjuvant chemotherapy in a cohort of Swedish patients with breast cancer. DESIGN: Exploratory clinical prospective longitudinal study with 6 and 12 months of follow-up. PARTICIPANTS: Forty women treated for breast cancer with adjuvant chemotherapy were included, and 33 women completed the study. MAIN OUTCOME MEASURES: The primary outcome was the proportion of participants meeting the health-enhancing physical activity guidelines, both in relative terms (perceived exertion using Borg's rate of perceived exertion scale) and absolute terms (metabolic equivalent). RESULTS: The proportion of participants meeting the guidelines when leisure-time physical activity was measured in terms of absolute intensity was 81 (25/31) to 94% (31/33) during chemotherapy, 93% (29/31) at 6-month follow-up and 87% (26/30) at 12-month follow-up. Women who had been physically active before their cancer diagnosis and women who had received information about physical activity were more physically active during chemotherapy. CONCLUSIONS: Swedish patients with breast cancer are generally more physically active during adjuvant chemotherapy than has been reported previously in international studies. Physical activity habits prior to cancer diagnosis and information about the benefits of physical activity appear to be important factors for higher levels of physical activity during and after chemotherapy.
OBJECTIVES: To describe changes in physical activity levels related to health-enhancing physical activity guidelines during and after adjuvant chemotherapy in a cohort of Swedish patients with breast cancer. DESIGN: Exploratory clinical prospective longitudinal study with 6 and 12 months of follow-up. PARTICIPANTS: Forty women treated for breast cancer with adjuvant chemotherapy were included, and 33 women completed the study. MAIN OUTCOME MEASURES: The primary outcome was the proportion of participants meeting the health-enhancing physical activity guidelines, both in relative terms (perceived exertion using Borg's rate of perceived exertion scale) and absolute terms (metabolic equivalent). RESULTS: The proportion of participants meeting the guidelines when leisure-time physical activity was measured in terms of absolute intensity was 81 (25/31) to 94% (31/33) during chemotherapy, 93% (29/31) at 6-month follow-up and 87% (26/30) at 12-month follow-up. Women who had been physically active before their cancer diagnosis and women who had received information about physical activity were more physically active during chemotherapy. CONCLUSIONS: Swedish patients with breast cancer are generally more physically active during adjuvant chemotherapy than has been reported previously in international studies. Physical activity habits prior to cancer diagnosis and information about the benefits of physical activity appear to be important factors for higher levels of physical activity during and after chemotherapy.
Authors: S Casla; P Hojman; I Márquez-Rodas; S López-Tarruella; Y Jerez; R Barakat; M Martín Journal: Clin Transl Oncol Date: 2014-06-04 Impact factor: 3.405
Authors: Madelyn Whitaker; Whitney A Welch; Jason Fanning; Cesar A Santa-Maria; Lisa A Auster-Gussman; Payton Solk; Seema A Khan; Swati A Kulkarni; William Gradishar; Juned Siddique; Siobhan M Phillips Journal: Support Care Cancer Date: 2022-04-30 Impact factor: 3.603
Authors: Elizabeth A Salerno; Eva Culakova; Amber S Kleckner; Charles E Heckler; Po-Ju Lin; Charles E Matthews; Alison Conlin; Lora Weiselberg; Jerry Mitchell; Karen M Mustian; Michelle C Janelsins Journal: J Clin Oncol Date: 2021-08-18 Impact factor: 50.717
Authors: H Helbrich; M Braun; C Hanusch; G Mueller; H Falk; R Flondor; N Harbeck; K Hermelink; R Wuerstlein; S Keim; F Neufeld; S Steins-Loeber; K Haertl Journal: Breast Cancer Res Treat Date: 2021-03-31 Impact factor: 4.872
Authors: Ian M Lahart; George S Metsios; Alan M Nevill; Amtul R Carmichael Journal: Int J Environ Res Public Health Date: 2014-05-20 Impact factor: 3.390
Authors: Yuan-Yuan Lei; Suzanne C Ho; Carol Kwok; Ashley Cheng; Ka Li Cheung; Roselle Lee; Winnie Yeo Journal: BMC Cancer Date: 2020-10-19 Impact factor: 4.430
Authors: Mohammad Mahdi Rafiei; Rahele Soltani; Mohammad Reza Kordi; Reza Nouri; Abbas Ali Gaeini Journal: Iran J Basic Med Sci Date: 2021-09 Impact factor: 2.699
Authors: Sahar Zaidi; Showket Hussain; Shalini Verma; Zubia Veqar; Asiya Khan; Sheeraz Un Nazir; Neha Singh; Jamal Ali Moiz; Pranay Tanwar; Anurag Srivastava; G K Rath; Ravi Mehrotra Journal: Front Oncol Date: 2018-01-11 Impact factor: 6.244